✅ Model Answer:
• Diagnosis: Vitamin B12 deficiency (malabsorption) — macrocytic anemia (Hb 8.0, MCV 108 fL), low reticulocyte count (0.8%), low platelets (140,000), low B12, normal folate. History of abdominal surgery and colostomy suggests malabsorption (ileal resection or terminal ileum dysfunction).
• Any other test: Elevated Methylmalonic Acid (MMA) — more specific for B12 deficiency, Elevated Homocysteine, Anti-intrinsic factor antibodies (rule out pernicious anemia), anti-parietal cell antibodies, Schilling test (if available), urinalysis for proteinuria (Imerslund-Gräsbeck syndrome), holotranscobalamin (if total B12 borderline).
• What to do next: Start IM hydroxocobalamin (1000 μg weekly for 4 weeks, then monthly). If dietary deficiency is purely due to malabsorption, IM B12 is required. Consider oral B12 (1000 μg/day) if malabsorption is mild. Monitor for hypokalemia (reticulocytosis can cause potassium shift).
• Follow-up plan: Check reticulocyte count in 3-7 days (should rise). Hb should improve in 2-4 weeks. Neurologic exam periodically (subacute combined degeneration). Continue B12 supplementation lifelong if malabsorption is permanent. Recheck B12, MMA in 3 months.

✅ Model Answer:
• Inadequate intake:
- Vegan/vegetarian diet (no animal products)
- Maternal B12 deficiency in breastfed infants
- Poor dietary diversity
• Malabsorption (most common in this case):
- Ileal resection: Terminal ileum is the site of B12 absorption
- Crohn's disease: Terminal ileum inflammation
- Celiac disease: Malabsorption
- Short bowel syndrome
- Pancreatic insufficiency: R-protein deficiency
- Bacterial overgrowth: Competition for B12
- Diphyllobothrium latum (fish tapeworm): Competition for B12
• Pernicious anemia (rare in children):
- Autoimmune destruction of gastric parietal cells → lack of intrinsic factor
- Associated with autoimmune conditions (type 1 diabetes, thyroiditis)
• Genetic disorders:
- Imerslund-Gräsbeck syndrome (selective B12 malabsorption)
- Transcobalamin II deficiency
- Methylmalonic aciduria with homocystinuria

✅ Model Answer:
• CBC:
- Hemoglobin: Low (mild to severe)
- MCV: Elevated (>100 fL) — macrocytic
- Reticulocyte count: Inappropriately low (ineffective erythropoiesis)
- WBC: Low-normal or low (leukopenia)
- Platelets: Low-normal or low (thrombocytopenia)
- Pancytopenia: In severe cases
• Peripheral smear:
- Macrocytes, oval macrocytes
- Hypersegmented neutrophils: ≥5 lobes (hallmark)
- Howell-Jolly bodies
- Pancytopenia (if severe)
• B12 studies:
- Vitamin B12: Low (<200 pg/mL)
- Methylmalonic acid (MMA): Elevated (more specific than B12)
- Homocysteine: Elevated
- Folate: Normal (to rule out folate deficiency)
- Anti-intrinsic factor antibodies: Positive in pernicious anemia

✅ Model Answer:
• MMA (Methylmalonic acid): A metabolic byproduct of propionate metabolism that requires vitamin B12 as a cofactor.
• In B12 deficiency: MMA accumulates → blood and urine MMA are elevated.
• Specificity: More specific for B12 deficiency than serum B12 alone.
• Advantages:
- Detects early B12 deficiency: Before serum B12 drops below normal.
- Distinguishes from folate deficiency: MMA is normal in folate deficiency.
- Useful when B12 levels are borderline: B12 200-300 pg/mL with elevated MMA confirms B12 deficiency.
• Limitations: Can be elevated in renal insufficiency (decreased clearance).
• Normal MMA: Excludes clinically significant B12 deficiency.

✅ Model Answer:
• For malabsorption (ileal resection, pernicious anemia):
- IM hydroxocobalamin: 1000 μg weekly for 4 weeks (loading), then 1000 μg monthly for life.
- Alternatively: IM cyanocobalamin 1000 μg monthly.
- Oral B12: 1000-2000 μg/day (if mild malabsorption or dietary deficiency).
• For dietary deficiency (vegans):
- Oral B12: 50-100 μg/day or 1000 μg weekly.
- Dietary counseling: Include B12-fortified foods or supplements.
• Response:
- Reticulocytosis: Peaks at 5-7 days.
- Hb rise: 1-2 g/dL per week.
- Neurologic improvement: May take months; may be incomplete if diagnosis is delayed.
• Monitor: Hypokalemia (due to increased erythropoiesis) — check potassium during early treatment.

✅ Model Answer:
• Subacute combined degeneration of the spinal cord:
- Pathology: Demyelination of dorsal columns (posterior columns) and corticospinal tracts.
- Symptoms:
• Early: Paresthesias (numbness, tingling) in hands and feet
• Progression: Ataxia, loss of vibration and position sense, weakness, spasticity, urinary incontinence
• Signs: Romberg sign positive, impaired proprioception, hyperreflexia (lower limbs), extensor plantar responses
• Reversibility: Early treatment can reverse symptoms; delayed treatment may cause permanent neurologic damage.
• Other neurologic:
- Peripheral neuropathy: Sensory loss, distal weakness
- Optic neuropathy: Vision loss, optic atrophy (rare)
- Cognitive impairment: Memory loss, confusion, dementia (if severe)
- Autonomic dysfunction: Orthostatic hypotension
• Psychiatric: Depression, irritability, psychosis.

✅ Model Answer:
• Intrinsic factor (IF): A glycoprotein produced by gastric parietal cells.
• Role: Binds to vitamin B12 in the stomach, protecting it from digestion, and facilitates its absorption in the terminal ileum (via cubilin receptor).
• Deficiency causes:
- Pernicious anemia: Autoimmune destruction of parietal cells → IF deficiency → B12 malabsorption.
- Gastrectomy: Loss of parietal cells → IF deficiency.
- Congenital IF deficiency: Rare genetic disorder.
• Testing:
- Anti-intrinsic factor antibodies: Detected in 50-70% of pernicious anemia cases (specific).
- Anti-parietal cell antibodies: Detected in 90% of pernicious anemia cases (less specific).
- Schilling test: Measures B12 absorption with and without IF (now rarely used).
• Treatment: IM B12 (bypasses IF requirement).

✅ Model Answer:
• Prognosis:
- Excellent with prompt diagnosis and treatment (B12 replacement).
- Hb: Normalizes within 4-8 weeks.
- Neurologic symptoms: May take months to improve; partial or complete recovery depending on duration of deficiency.
- Irreversible neurologic damage: If untreated for >6-12 months.
- Pernicious anemia: Requires lifelong IM B12.
- Malabsorption (ileal resection): Lifelong IM B12 required.
• Long-term follow-up:
- Recheck Hb: 4-6 weeks after starting treatment.
- Recheck B12, MMA: 3-6 months (to ensure repletion).
- Neurologic exam: Monitor for improvement of sensory/motor deficits.
- Growth and development: Monitor for catch-up growth.
- Dietary counseling: If dietary deficiency, ensure B12-rich foods or supplements.
- Genetic counseling: If congenital disorder (Imerslund-Gräsbeck).
- Lifelong monitoring: For patients with malabsorption or pernicious anemia.